Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $250.83 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $69.70 | 4 | $0 (2021) |
| Allergan, Inc. | $46.69 | 3 | $0 (2022) |
| UCB, Inc. | $27.24 | 1 | $0 (2021) |
| GENZYME CORPORATION | $24.26 | 1 | $0 (2021) |
| Dermavant Sciences, Inc. | $21.85 | 1 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $18.70 | 1 | $0 (2024) |
| Genentech USA, Inc. | $18.69 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $12.85 | 1 | $0 (2023) |
| Medimetriks Pharmaceuticals, Inc. | $10.85 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.70 | 1 | SUN PHARMACEUTICAL INDUSTRIES INC. ($18.70) |
| 2023 | $34.70 | 2 | Dermavant Sciences, Inc. ($21.85) |
| 2022 | $18.95 | 1 | Allergan, Inc. ($18.95) |
| 2021 | $99.20 | 5 | Allergan, Inc. ($27.74) |
| 2020 | $18.69 | 1 | Genentech USA, Inc. ($18.69) |
| 2018 | $37.04 | 2 | AbbVie, Inc. ($37.04) |
| 2017 | $23.55 | 2 | AbbVie, Inc. ($12.70) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Dermatology | ||||||
| 09/09/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: DERMATOLOGY | ||||||
| 06/16/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Dermatology | ||||||
| 11/07/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/09/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/07/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: IMMUNOLOGY | ||||||
| 09/08/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Immunology | ||||||
| 08/12/2021 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: Immunology | ||||||
| 05/07/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/07/2020 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: BioOncology | ||||||
| 04/13/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Immunology | ||||||
| 01/03/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Immunology | ||||||
| 11/22/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Immunology | ||||||
| 05/26/2017 | Medimetriks Pharmaceuticals, Inc. | Neo-Synalar Cream (Drug), Sumadan Wash | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 228 | 419 | $36,350 | $18,057 |
| 2022 | 5 | 155 | 285 | $22,775 | $10,527 |
| 2021 | 6 | 221 | 417 | $29,585 | $15,338 |
| 2020 | 3 | 63 | 158 | $7,670 | $3,106 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 112 | 158 | $18,960 | $10,492 | 55.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 42 | 63 | $7,560 | $2,899 | 38.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 22 | 31 | $5,115 | $2,647 | 51.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 26 | 26 | $2,600 | $1,322 | 50.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 26 | 141 | $2,115 | $697.46 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 93 | $10,940 | $6,040 | 55.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 29 | 47 | $5,640 | $1,979 | 35.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 15 | 20 | $3,300 | $1,350 | 40.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 25 | 113 | $1,695 | $587.76 | 34.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 12 | 12 | $1,200 | $569.61 | 47.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 98 | $9,800 | $6,941 | 70.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 29 | 40 | $6,600 | $3,212 | 48.7% |
| 17000 | Destruction of skin growth | Office | 2021 | 43 | 58 | $6,960 | $2,549 | 36.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 35 | 190 | $2,850 | $974.33 | 34.2% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 20 | 20 | $2,000 | $949.75 | 47.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 11 | 11 | $1,375 | $711.46 | 51.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 35 | $3,500 | $1,736 | 49.6% |
| 17000 | Destruction of skin growth | Office | 2020 | 17 | 22 | $2,640 | $892.89 | 33.8% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 15 | 101 | $1,530 | $476.57 | 31.1% |
About Dr. Richard Stone, MD
Dr. Richard Stone, MD is a Dermatology healthcare provider based in Sterling Heights, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1174500011.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Stone, MD has received a total of $250.83 in payments from pharmaceutical and medical device companies, with $18.70 received in 2024. These payments were reported across 14 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($250.83).
As a Medicare-enrolled provider, Stone has provided services to 667 Medicare beneficiaries, totaling 1,279 services with total Medicare billing of $47,028. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Sterling Heights, MI
- Active Since 12/30/2005
- Last Updated 02/25/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174500011
Products in Payments
- Humira (Biological) $49.74
- BOTOX (Biological) $46.69
- Cimzia (Drug) $27.24
- DUPIXENT (Biological) $24.26
- VTAMA (Drug) $21.85
- SKYRIZI (Biological) $19.96
- Winlevi (Drug) $18.70
- Erivedge (Biological) $18.69
- COSENTYX (Drug) $12.85
- Neo-Synalar Cream (Drug) $10.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.